Digital Long-term Follow-up of Patients With Coronary Artery Disease
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: "HeartCheck".
- Who it may be relevant to
- Registry conditions: Coronary Artery Disease. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Norway
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Digital Long-term Follow-up of Patients With Coronary Artery Disease: a Randomized Controlled Trial
Overview
The need for better follow-up of AMI patients combined with recent developments in the digital area prompted the Department of Cardiology (HJE) at Oslo University Hospital (OUS) Ullevål, in collaboration with the Department of Digital Health Research (DIG) at OUS to develop a digital solution for long-term follow-up after AMI. The overall goal of the digital solution is to increase knowledge and awareness about important lifestyle measures and CV risk factors in patients who have survived an AMI, and to make it easy for the patients to monitor their own risk factors and attainment of treatment goals during long-term follow-up. Further, the HeartCheck seeks to provide guidance to ensure medication adherence. In this project, we study whether this newly developed app (HeartCheck), through education, regular reminders and easily understandable goals for secondary prevention, can improve risk factor control and drug adherence during long-term follow-up after AMI. A randomized controlled trial (RCT) is the chosen study design, being the gold standard for testing effectiveness of interventions.
Interventions
- Device "HeartCheck"
a digital application developed specifically for patient support during follow-up after acute myocardial infarction or PI for stable coronary artery disease
Primary outcome measures
- Proportion of patients fulfilling 4 evidence-based goals for risk factor control [Time frame: 12 months after inclusion in the study]
Eligibility criteria
Inclusion criteria
- >18 years of age
- survived a recent (<30 days) AMI and/or PCI
- access to a smartphone or tablet
- signed written informed consent
Exclusion criteria
- patient does not understand Norwegian
- patient is unable to comply with the study procedures due to severe comorbidities or high age
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Supportive care
Study locations
Norway · 2 centers
- Sørlandet Hospital Arendal — Arendal
- Oslo University Hospital Ullevål — Oslo
Identifiers
NCT: NCT07720349 · 25/07916